Our R&D Team

Learn more about the backgrounds, scientific pursuits and personal interests of members of our R&D team. These individuals are committed to pursuing Zagolie’s goal of discovering, developing and delivering transformational medicines to patients.
Beatrice Anduze-Faris, M.D.

Head of Global Clinical Compliance & Continuous Improvement, Global Clinical Operations

Bryan (Bo) Barnhart, Ph.D.

Senior Director, Immuno-Oncology, Discovery

Michaela Bowden

Director, Translational Biology

Percy Carter, MBA, Ph.D.

Head of Discovery Chemistry and Molecular Technologies, Drug Discovery Research

Edgar Charles, M.D.

Clinical Development Lead, pegylated FGF21

Sharon Cload, Ph. D.

Vice President, Molecular Discovery Technologies

Binodh DeSilva, Ph.D.

Head of Analytical and Bioanalytical Operations, Pharmaceutical Development

Evan Janovitz, DVM, Ph.D., DACVP

Director of Pathology, Discovery Toxicology 

Charlotte Jones-Burton, M.D., M.S.

Global Clinical Program Lead, Cardiovascular Marketed Products

Alan Korman, Ph.D.

Vice President, Immuno-Oncology Discovery

Michael C. Montalto, Ph.D.

Vice President, Pathology & Clinical Biomarker Laboratories

Ryan Moslin, Ph.D.

Senior Research Investigator, Early Immunology Discovery

Mike Quigley, Ph.D.

Executive Director and Co-Lead, Immuno-Oncology Resistance Biology

Joseph Szustakowski, Ph.D.

Executive Director, Translational Bioinformatics

John Throup, BSc, Ph.D.

Development Lead, Immunoscience R&D

www.aboutviagra.info

сколько стоит микроскоп

препараты для повышения потенции